Efficacy of Pharmacological Stimulation of Brown and White Fat in Lean and Obese Young Adults

Trial Profile

Efficacy of Pharmacological Stimulation of Brown and White Fat in Lean and Obese Young Adults

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 May 2017

At a glance

  • Drugs Mirabegron (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Acronyms MiraBAT
  • Most Recent Events

    • 08 May 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
    • 08 May 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Oct 2017.
    • 08 May 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top